1-17 of 17
Celia Salanoubat
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Versus Late Onset of ESA in Lower Risk Anemic MDS Patients: Results of the GFM Randomized Phase III EPO-Pretar Trial

Sophie Park, Bohrane Slama, Marius Moldovan, David Rombaut, Marie Templé, Aspasia Stamatoullas, Maud D'Aveni, Stephane Cheze, Sylvain Thepot, Jose Miguel Torregrosa Diaz, Sophie Dimicoli, Mathieu Meunier, Kamel Laribi, Reza Tabrizi, Anne Banos, Alice Garnier, Celia Salanoubat, Adrien Contejean, Mael Heiblig, Laurent Pascal, Clemence Santana, Ali Arar, Ramdane Tekrane, Fatiha Chermat, Olivier Kosmider, Michaela Fontenay, Pierre Fenaux
Journal: Blood
Blood (2024) 144 (Supplement 1): 349.
https://doi.org/10.1182/blood-2024-194510
Published: 2024
Journal Articles

A Phase 2 Prospective Study Evaluating Low-Dose Deferasirox in Patients with Low-Risk Myelodysplastic Syndrome Resistant or Relapsing after Erythropoietin Stimulating Agents (LODEFI)

Mathieu Meunier, Sylvain Thepot, Stanislas Nimubona, Mélanie Véloso, Thibaud Lefebvre, Karim Zoubida, Martine Ropert-Bouchet, Frederic Garban, Shanti Ame, Abdesssamia Gandoul, Claire Reynes, Celia Salanoubat, Sébastien Maury, Kamel Laribi, Pirayeh Eftekhari, Jacques Delaunay, Geoffroy Venton, Clemence Santana, Stephane Cheze, Sophie Dimicoli-Salazar, Mathieu Molimard, Valérie Rolland-Neyret, Sandra David-Tchouda, Sophie Park
Journal: Blood
Blood (2024) 144 (Supplement 1): 1826.
https://doi.org/10.1182/blood-2024-198104
Published: 2024
Journal Articles

Efficacy of CAR-T Cells in Primary Central Nervous System Lymphomas: The French Experience of the National LOC Network

Choquet Sylvain, Magali Le Garff-Tavernier, Laetitia Souchet, Damien Roos Weil, Veronique Morel, Madalina Uzunov, Carole Metz, Stephanie Nguyen Quoc, Nathalie Jacque, Nicolas Gauthier, Lise Willems, Agathe Waultier, Celia Salanoubat, Roch Houot, Renata Ursu, Maryline Barrie, Guido Ahle, Carole Soussain, Marion Alcantara, Caroline Houillier
Journal: Blood
Blood (2022) 140 (Supplement 1): 7540–7541.
https://doi.org/10.1182/blood-2022-167784
Published: 2022
Journal Articles

CD19 CAR T-Cell Therapy in Patients with Relapse/Refractory DLBCL: Retrospective Analysis of the Eligibility Criteria

Jérôme Paillassa, MD, Roberta Di Blasi, Sylvie Chevret, Sophie Bernard, Michael Darmon, MD PhD, Veronique Meignin, Bénédicte Deau-Fischer, Vincent Camus, Rene-Olivier Casasnovas, MD, Guillaume Cartron, Driss Chaoui, Vincent Delwail, MD, Pierre Feugier, MD PhD, Luc Mathieu Fornecker, MD PhD, Emmanuel Gyan, MD PhD, Corinne Haioun, MD PhD, Frederique Kuhnowski, MD, Jean Valère Malfuson, MD, Jean-Pierre Marolleau, MD PhD, Veronique Morel, Gandhi Damaj, MD PhD, Anne Quinquenel, MD, Sophie Rigaudeau, MD, Celia Salanoubat, Géraldine Salmeron, David Sibon, MD PhD, Elie Azoulay, MD PhD, Maxime Berquier, Catherine Thieblemont, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2887.
https://doi.org/10.1182/blood-2019-129532
Published: 2019
Journal Articles

Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL

Clinical Trials & Observations
Philippe Rousselot, Marie Magdelaine Coudé, Nicola Gokbuget, Carlo Gambacorti Passerini, Sandrine Hayette, Jean-Michel Cayuela, Françoise Huguet, Thibaut Leguay, Patrice Chevallier, Celia Salanoubat, Caroline Bonmati, Magda Alexis, Mathilde Hunault, Sylvie Glaisner, Philippe Agape, Christian Berthou, Eric Jourdan, José Fernandes, Laurent Sutton, Anne Banos, Oumedaly Reman, Bruno Lioure, Xavier Thomas, Norbert Ifrah, Marina Lafage-Pochitaloff, Anne Bornand, Laure Morisset, Valérie Robin, Heike Pfeifer, Andre Delannoy, Josep Ribera, Renato Bassan, Marc Delord, Dieter Hoelzer, Herve Dombret, Oliver G. Ottmann
Journal: Blood
Blood (2016) 128 (6): 774–782.
https://doi.org/10.1182/blood-2016-02-700153
Published: 2016
Includes: Supplemental data
Journal Articles

Is Azacitidine (AZA) Really Effective in High Risk MDS Patients with Chromosome 7 Abnormalities (Abn 7)? Results of a Retrospective Study From the GFM and GESMD Registries

María Díez-Campelo, MD, PhD, Raphael Itzykson, Silvia M Rojas, Céline Berthon, MD, PhD, Elisa Luño, Odile Beyne-Rauzy, Jaime Perez-Oteyza, Norbert Vey, MD, PhD, Joan Bargay, Sophie Park, Teresa Cedena, Dominique Bordessoule, MD, PhD, Juan A Muñoz, Emmanuel Gyan, MD, PhD, Esperanza Such, Sorin Visanica, MD, Luis Benlloch, Stéphane de Botton, MD, PhD, Jesús M Hernández-Rivas, Shanti Ame, MD, Aspasia Stamatoullas, MD, Jacques Delaunay, MD, Celia Salanoubat, MD, Françoise Isnard, MD, Guillermo Sanz, Romain Guieze, MD, Consuelo Cañizo, MD, PhD, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1713.
https://doi.org/10.1182/blood.V120.21.1713.1713
Published: 2012
Journal Articles

Dasatinib (Sprycel®) and Low Intensity Chemotherapy for First-Line Treatment in Patients with De Novo Philadelphia Positive ALL Aged 55 and Over: Final Results of the EWALL-Ph-01 Study

Philippe Rousselot, MD, PhD, Marie Magdeleine Coudé, Françoise Huguet, Marina Lafage, Thibaut Leguay, Celia Salanoubat, MD, Francis Witz, MD, Magda Alexis, MD, Maud Janvier, MD, Mathilde Hunault, MD, PhD, Philippe Agape, Christian Berthou, MD, Eric Jourdan, MD, José Fernandes, MD, Laurent Sutton, Anne Banos, Oumedaly Reman, MD, Bruno Lioure, MD, Jean-Michel Cayuela, PhD, Sandrine Hayette, Nicola Gokbuget, MD, Dieter Hoelzer, MD, Andre Delannoy, MD, Carlo Gambacorti-Passerini, MD, Renato Bassan, MD, Josep-Maria Ribera, MD, PhD, Sebastian Giebel, MD, Herve Dombret, Oliver G. Ottmann, MD
Journal: Blood
Blood (2012) 120 (21): 666.
https://doi.org/10.1182/blood.V120.21.666.666
Published: 2012
Journal Articles

Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine

Clinical Trials & Observations
Raphael Itzykson, Sylvain Thépot, Bruno Quesnel, Francois Dreyfus, Odile Beyne-Rauzy, Pascal Turlure, Norbert Vey, Christian Recher, Caroline Dartigeas, Laurence Legros, Jacques Delaunay, Célia Salanoubat, Sorin Visanica, Aspasia Stamatoullas, Francoise Isnard, Anne Marfaing-Koka, Stephane de Botton, Youcef Chelghoum, Anne-Laure Taksin, Isabelle Plantier, Shanti Ame, Simone Boehrer, Claude Gardin, C. L. Beach, Lionel Adès, Pierre Fenaux, on behalf of the Groupe Francophone des Myelodysplasies (GFM)
Journal: Blood
Blood (2011) 117 (2): 403–411.
https://doi.org/10.1182/blood-2010-06-289280
Published: 2011
Journal Articles

A Prognostic Score for Overall Survival (OS) with Azacitidine (AZA) In Higher Risk MDS Based on 282 Patients (pts), and Validated In 175 Pts From the AZA 001 Trial

Raphael Itzykson, Sylvain Thepot, Bruno Quesnel, Francois Dreyfus, Odile Beyne-Rauzy, Pascal Turlure, Christian Recher, Caroline Dartigeas, Norbert Vey, MD, Laurence Legros, Jacques Delaunay, Celia Salanoubat, Sorin Visanica, Aspasia Stamatoullas, Françoise Isnard, MD, Anne Marfaing-Koka, Stephane De Botton, Youcef Chelgoum, Anne-Laure Taksin, Isabelle Plantier, Shanti Ame, Simone Boehrer, Claude Gardin, CL Beach, PharmD, Lionel Ades, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3996.
https://doi.org/10.1182/blood.V116.21.3996.3996
Published: 2010
Journal Articles

A Phase I-II Study of Vorinostat and Low Dose Cytarabine for Patients Treated for High Risk Myelodysplastic with Azacytidine Failure: The GFM-VOR2007 Study

Thomas Prebet, M.D., Ph.D., Thorsten Braun, M.D., Ph.D., Odile Beyne Rauzy, Francois Dreyfus, Aspasia Stamatoullas, Eric Wattel, Shanti Ame, MD, Emmanuel Raffoux, MD, Jacques Delaunay, Celia Salanoubat, Isabelle Mathieu, Fatiha Chermat, Lionel Ades, Pierre Fenaux, MD, PhD, Norbert Vey, MD
Journal: Blood
Blood (2010) 116 (21): 4003.
https://doi.org/10.1182/blood.V116.21.4003.4003
Published: 2010
Journal Articles

Dasatinib (Sprycel®) and Low Intensity Chemotherapy for First-Line Treatment In Elderly Patients with De Novo Philadelphia Positive ALL (EWALL-PH-01): Kinetic of Response, Resistance and Prognostic Significance

Philippe Rousselot, MD, PhD, Jean Michel Cayuela, MD, PhD, Sandrine Hayette, MD, PhD, Christian Récher, MD, PhD, Thibaut Leguay, MD, Celia Salanoubat, MD, Francis Witz, MD, Magda Alexis, MD, Mathilde Hunault, MD, PhD, Maud Janvier, MD, Philippe Agape, MD, Christian Berthou, MD, PhD, Eric Jourdan, MD, José Fernandes, MD, Laurent Sutton, MD, Anne Banos, MD, Oumedaly Reman, MD, Bruno Lioure, MD, Xavier Thomas, MD, PhD, Norbert Ifrah, MD, Nicola Gokbuget, MD, Dieter Hoelzer, MD, Andre Delannoy, MD, Renato Bassan, MD, Jose M. Ribera, MD, PhD, Sebastian Giebel, MD, PhD, Herve Dombret, MD, Oliver G. Ottmann, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 172.
https://doi.org/10.1182/blood.V116.21.172.172
Published: 2010
Journal Articles

Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)

Clinical Trials & Observations
Sylvain Thepot, Raphael Itzykson, Valerie Seegers, Emmanuel Raffoux, Bruno Quesnel, Yasmine Chait, Lucile Sorin, Francois Dreyfus, Thomas Cluzeau, Jacques Delaunay, Laurence Sanhes, Virginie Eclache, Caroline Dartigeas, Pascal Turlure, Stephanie Harel, Celia Salanoubat, Jean-Jacques Kiladjian, Pierre Fenaux, Lionel Adès
Journal: Blood
Blood (2010) 116 (19): 3735–3742.
https://doi.org/10.1182/blood-2010-03-274811
Published: 2010
Journal Articles

Azacytidine (AZA) as First Line Therapy in AML: Results of the French ATU Program.

Sylvain Thépot, Raphael Itzykson, Valerie Seegers, Christian Recher, Bruno Quesnel, Jacques Delaunay, MD, Thomas Cluzeau, Anne Marfaing Koka, Aspasia Stamatoullas, MP Chaury, Caroline Dartigeas, Stéphane Cheze, Celia Salanoubat, Pierre Morel, MD, Isabelle Plantier, Anne-Laure Taksin, MD, Jean Pierre Marolleau, MD,, Cecile Pautas, MD, Eric Wattel, MD, PhD, Francoise Isnard, Laurence Sanhes, Stephanie Harel, Stephane de Botton, MD, PhD, Yasmine Chait, Madalina Uzunov, Agnes Guerci, MD, PhD, Mehdi Dahoun, Norbert Vey, MD, PhD,, Herve Dombret, MD, PhD,, Francois Dreyfus, MD, PhD, Lionel Ades, MD,, Pierre Fenaux, Claude Gardin
Journal: Blood
Blood (2009) 114 (22): 843.
https://doi.org/10.1182/blood.V114.22.843.843
Published: 2009
Journal Articles

Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories

Clinical Trials & Observations
Régis Peffault de Latour, Jean Yves Mary, Célia Salanoubat, Louis Terriou, Gabriel Etienne, Mohamad Mohty, Sophie Roth, Sophie de Guibert, Sebastien Maury, Jean Yves Cahn, Gerard Socié
Journal: Blood
Blood (2008) 112 (8): 3099–3106.
https://doi.org/10.1182/blood-2008-01-133918
Published: 2008
Includes: Supplemental data
Journal Articles

Partial Efficacy of Bortezomib on Acute Myeloid Leukemia (AML) Cells in a Patient with Concomitant Multiple Myeloma and AML.

Bertrand Joly, Patrick Quillet, Celia Salanoubat, Selwa Bouledroua, Charlotte Petitdidier, Alain Devidas
Journal: Blood
Blood (2007) 110 (11): 4379.
https://doi.org/10.1182/blood.V110.11.4379.4379
Published: 2007
Journal Articles

Paroxysmal Nocturnal Hemoglobinuria (PNH): Long-Term Epidemiological Study.

Regis Peffault de Latour, MD, Jean Y. Mary, PhD, Celia Salanoubat, MD, Louis Terriou, MD, Gabriel Etienne, MD, Mohamad Mohty, MD, PhD, Sophie Roth, MD, Sophie de Guibert, MD, Jean Y. Cahn, MD, Gerard Socie, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 973.
https://doi.org/10.1182/blood.V108.11.973.973
Published: 2006
Journal Articles

B Cell Receptor (BCR) Ligation Enhances Cell Survival in Progressive Chronic Lymphocytic Leukemia (CLL).

Pierre-Antoine Deglesne, Natalie Chevallier, Remi Letestu, Celia Salanoubat, Laurence Sanhes, Joelle Nataf, Nadine Varin-Blank, Florence Ajchenbaum-Cymbalista
Journal: Blood
Blood (2004) 104 (11): 966.
https://doi.org/10.1182/blood.V104.11.966.966
Published: 2004